Park Medi World Limited (NSE:PARKHOSPS)

India · Delayed Price · Currency is INR

292.65

+13.35 (4.78%)

At close: Jul 31, 2026

84.29% (1Y)

Market Cap	126.40B
Revenue (ttm)	16.79B +20.5%
Net Income	2.58B +25.8%
EPS	6.87 +28.7%
Shares Out	431.93M
PE Ratio	42.60
Forward PE	35.69
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,484,565
Open	281.30
Previous Close	279.30
Day's Range	279.30 - 301.85
52-Week Range	138.10 - 305.00
Beta	n/a
Analysts	Strong Buy
Price Target	350.00 (+19.6%)
Earnings Date	Aug 3, 2026

About Park Medi World

Park Medi World Limited operates a network of hospitals. The company provides cardiac sciences, neurosciences - brain and spine, plastic and cosmetic surgery, general and laparoscopic surgery, renal sciences and kidney transplant, bone, orthopaedics, joint replacement and sports medicine, gastroenterology and surgical gastroenterology, cancer care, bone marrow transplant, iMARS / robot-assisted surgery. It also offers bariatric surgery, anaesthesiology, critical care, chest and respiratory diseases, dental care, dermatology, endocrinology, paed... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 2005

Employees 5,911

Stock Exchange National Stock Exchange of India

Ticker Symbol PARKHOSPS

Full Company Profile

Financial Performance

In fiscal year 2026, Park Medi World's revenue was 16.79 billion, an increase of 20.51% compared to the previous year's 13.94 billion. Earnings were 2.58 billion, an increase of 25.81%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for PARKHOSPS stock is "Strong Buy." The 12-month stock price target is ₹350.00, which is an increase of 19.60% from the latest price.

Price Target

₹350.00

(19.60% upside)

Analyst Consensus: Strong Buy

Stock Forecasts